Phenotyping Overactive Bladder – Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI‐RS 2025
Authors:
- Michel WyndaeleMWMichel Wyndaele
- Michael SamarinasMSMichael Samarinas
- Apostolos ApostolidisAAApostolos Apostolidis
- D. Carolina OchoaDOD. Carolina Ochoa
- Giovanni MosielloGMGiovanni Mosiello
- Brigitte SchurchBSBrigitte Schurch
- Pradeep TyagiPTPradeep Tyagi
- Alan WeinAWAlan Wein
- Paul AbramsPAPaul Abrams
- John E. SpeichJSJohn E. Speich
Open Access
- 22 October 2025
- journal article
- review article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 904-913
Abstract
Introduction: Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1. Personalized treatment and escalation pathways based on OAB profiling may lead to faster OAB symptom control and quality of life improvement, reduced cumulative side effects and costs, and improved treatment adherence. Methods: A Think Tank at the International Consultation on Incontinence‐Research Society (ICI‐RS) 2025 discussed the question, “Can OAB management be improved by phenotyping, and targeting therapy according to urgency type and other characteristics?” The group discussed the current literature on this topic and developed a list of research questions and strategies to help shape the future of the field. Results: Tailored combination of antimuscarinics and/or beta3 agonists, with botulinum toxin A (BTX‐A) and/or sacral nerve stimulation (SNS) was considered a high priority research topic. Profile‐based individual treatment selection and delivery protocols for BTX‐A and SNS are potential means to improve outcomes, as is the early escalation to BTX‐A and SNS in the treatment pathway of both adults and children. Finally, phenotype‐based treatment requires tight treatment outcome follow‐up and possible adjustment (including re‐phenotyping) for which tools need to be developed. Conclusion: Development and validation of a patient‐based flow‐chart to replace the current stepwise approach in OAB management will allow tailored treatment, aimed to improve therapeutic success, and to reduce side effects.Keywords
This publication has 54 references indexed in Scilit:
- International Continence Society best practice statement for use of sacral neuromodulationNeurourology and Urodynamics, 2018
- Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statementNeurourology and Urodynamics, 2017
- Long‐term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivityNeurourology and Urodynamics, 2017
- MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin‐A injectionNeurourology and Urodynamics, 2017
- Less is more—A pilot study evaluating one to three intradetrusor sites for injection of OnabotulinumtoxinA for neurogenic and idiopathic detrusor overactivityNeurourology and Urodynamics, 2016
- Intermittent sacral neuromodulation for idiopathic urgency urinary incontinence in womenNeurourology and Urodynamics, 2015
- Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivityNeurourology and Urodynamics, 2013
- Randomized prospective crossover study of interstim lead wire placement with curved versus straight styletNeurourology and Urodynamics, 2013
- Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: Long‐term follow‐upNeurourology and Urodynamics, 2011
- Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunctionNeurourology and Urodynamics, 2008